UniProtKB/Swiss-Prot P00480: Variant p.Ser90Arg

Ornithine carbamoyltransferase, mitochondrial
Gene: OTC
Chromosomal location: Xp21.1
Variant information

Variant position:  90
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants have been found in patients and disease-association is reported in literature. However, this classification is not a definitive assessment of variant pathogenicity.
  • Polymorphism: No disease-association has been reported.
  • Unclassified: Variants have been found in patients but disease-association remains unclear.

Residue change:  From Serine (S) to Arginine (R) at position 90 (S90R, p.Ser90Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. Note=The disease is caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In OTCD.
Any additional useful information about the variant.



Sequence information

Variant position:  90
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  354
The length of the canonical sequence.

Location on the sequence:   KGEYLPLLQGKSLGMIFEKR  S TRTRLSTETGFALLGGHPCF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCF

Mouse                         KGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPSF

Rat                           KGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPSF

Bovine                        KGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCF

Sheep                         KGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCF

Chicken                       KGEYLPLMQGKSLAMIFEKRSTRTRLSAETGFALLGGHSSF

Baker's yeast                 QSNHLKLL-GRTIALIFTKRSTRTRISTEGAATFFGAQPMF

Fission yeast                 RSVQMSGLSSQNVAMIFSKRSTRTRVSVESAVSCLGGNAMF

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 33 – 354 Ornithine carbamoyltransferase, mitochondrial
Region 90 – 94 Ornithine and carbamoyl phosphate binding
Modified residue 70 – 70 N6-acetyllysine; alternate
Modified residue 70 – 70 N6-succinyllysine; alternate
Modified residue 80 – 80 N6-succinyllysine
Modified residue 88 – 88 N6-acetyllysine; alternate
Modified residue 88 – 88 N6-succinyllysine; alternate


Literature citations

No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.